Owens & Minor Inc OMI
We take great care to ensure that the data presented and summarized in this overview for OWENS & MINOR INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OMI
View all-
Black Rock Inc. New York, NY11.6MShares$79.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$61.2 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.91MShares$33.7 Million1.59% of portfolio
-
Coliseum Capital Management, LLC Rowayton, CT4.79MShares$32.8 Million4.38% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.7MShares$32.3 Million0.02% of portfolio
-
State Street Corp Boston, MA3.19MShares$21.9 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.31MShares$15.8 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.7MShares$11.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.45MShares$9.94 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.43MShares$9.82 Million0.0% of portfolio
Latest Institutional Activity in OMI
Top Purchases
Top Sells
About OMI
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Insider Transactions at OMI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 10
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.69%
|
$560,000
$7.19 P/Share
|
|
Apr 09
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
225,000
+1.92%
|
$1,575,000
$7.39 P/Share
|
|
Apr 08
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
105,000
+0.92%
|
$735,000
$7.96 P/Share
|
|
Apr 07
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
240,000
+2.11%
|
$1,680,000
$7.84 P/Share
|
|
Apr 04
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
128,356
+1.16%
|
$1,026,848
$8.14 P/Share
|
|
Apr 03
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
160,000
+1.46%
|
$1,280,000
$8.53 P/Share
|
|
Mar 20
2025
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,578
-1.6%
|
$45,780
$10.09 P/Share
|
|
Mar 20
2025
|
Jonathan A Leon EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,961
-0.86%
|
$19,610
$10.09 P/Share
|
|
Mar 20
2025
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
5,551
-2.19%
|
$55,510
$10.09 P/Share
|
|
Mar 20
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,734
-2.23%
|
$27,340
$10.09 P/Share
|
|
Mar 20
2025
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
1,977
-1.72%
|
$19,770
$10.09 P/Share
|
|
Mar 20
2025
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,715
-1.23%
|
$147,150
$10.09 P/Share
|
|
Mar 20
2025
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,059
-0.85%
|
$10,590
$10.09 P/Share
|
|
Mar 04
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
800,000
+7.0%
|
$7,200,000
$9.75 P/Share
|
|
Mar 03
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
BUY
Grant, award, or other acquisition
|
Direct |
69,743
+36.22%
|
-
|
|
Mar 03
2025
|
Michael Wayne Lowry SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
28,166
+18.45%
|
-
|
|
Mar 03
2025
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
BUY
Grant, award, or other acquisition
|
Direct |
123,391
+32.79%
|
-
|
|
Mar 03
2025
|
Jonathan A Leon EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
134,121
+31.95%
|
-
|
|
Mar 03
2025
|
Snehashish Sarkar |
BUY
Grant, award, or other acquisition
|
Direct |
59,013
+33.93%
|
-
|
|
Mar 03
2025
|
Edward A Pesicka President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
445,279
+27.07%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.27M shares |
|---|---|
| Open market or private purchase | 3.83M shares |
| Payment of exercise price or tax liability | 156K shares |
|---|---|
| Open market or private sale | 92.9K shares |
| Bona fide gift | 70.9K shares |